MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs
Clinical trial NCT02582775 · COMPLETED
Trial details
- NCT number
- NCT02582775
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2022-11-15
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.